Related Experiment Video

Updated: Jul 10, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Molecular basis for the inhibition of p53 by Mdmx

Grzegorz M Popowicz1, Anna Czarna, Ulli Rothweiler

  • 1Max Planck Institute for Biochemistry, Martinsried, Germany.

Cell Cycle (Georgetown, Tex.)
|October 17, 2007
PubMed

Insights

Mdmx protein interaction with p53 differs from Mdm2, requiring specific inhibitors for full p53 activation in cancer therapy. This structural insight guides the development of novel anti-cancer compounds targeting Mdmx.

Area of Science:

  • Molecular Biology
  • Structural Biology
  • Oncology

Background:

  • Mdm2 and Mdmx are key negative regulators of the p53 tumor suppressor.
  • Their precise mechanisms in controlling p53 stability and activity remain incompletely understood.

Purpose of the Study:

  • To elucidate the structural basis of Mdmx-p53 interaction.
  • To compare Mdmx-p53 binding with the well-characterized Mdm2-p53 complex.
  • To inform the development of targeted cancer therapies.

Main Methods:

  • X-ray crystallography to determine the structure of the Mdmx N-terminal domain bound to a p53 peptide.
  • Binding assays to evaluate the efficacy of known Mdm2-p53 inhibitors (nutlins) against Mdmx-p53 interaction.

Main Results:

  • The crystal structure reveals conserved Mdm2-p53 interaction features but a significantly altered Mdmx hydrophobic cleft.
  • Specific sidechains within Mdmx's p53-binding pocket partially obstruct the cleft.
  • Nutlins, potent Mdm2-p53 inhibitors, showed limited ability to disrupt the Mdmx-p53 interaction.

Conclusions:

  • The distinct structural features of the Mdmx-p53 complex necessitate Mdmx-specific inhibitors.
  • Compounds targeting Mdmx are crucial to complement Mdm2-specific agents for complete p53 activation in cancer treatment.
  • This study provides a structural rationale for developing novel, selective Mdmx inhibitors.

More Related Videos

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method09:32

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method

Published on: September 10, 2017

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...